Literature DB >> 35333966

HIV-1 restriction by SERINC5.

Lucía Cano-Ortiz1,2, Tom Luedde1, Carsten Münk3.   

Abstract

Serine incorporator 5 (SERINC5 or SER5) is a multipass transmembrane protein with ill-defined cellular activities. SER5 was recently described as a human immunodeficiency virus 1 (HIV-1) restriction factor capable of inhibiting HIV-1 that does not express its accessory protein Nef (Δ Nef). SER5 incorporated into the viral membrane impairs the entry of HIV-1 by disrupting the fusion between the viral and the plasma membrane after envelope receptor interaction induced the first steps of the fusion process. The mechanisms of how SER5 prevents membrane fusion are not fully understood and viral envelope proteins were identified that escape the SER5-mediated restriction. Primate lentiviruses, such as HIV-1 and simian immunodeficiency viruses (SIVs), use their accessory protein Nef to downregulate SER5 from the plasma membrane by inducing an endocytic pathway. In addition to being directly antiviral, recent data suggest that SER5 is an important adapter protein in innate signaling pathways leading to the induction of inflammatory cytokines. This review discusses the current knowledge about HIV-1 restriction by SER5.
© 2022. The Author(s).

Entities:  

Keywords:  HIV-1; Nef; Restriction factors; SERINC5

Year:  2022        PMID: 35333966     DOI: 10.1007/s00430-022-00732-x

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  56 in total

Review 1.  Role of HIV-1 Vpu protein for virus spread and pathogenesis.

Authors:  Masako Nomaguchi; Mikako Fujita; Akio Adachi
Journal:  Microbes Infect       Date:  2008-07-10       Impact factor: 2.700

Review 2.  Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all.

Authors:  Belete A Desimmie; Krista A Delviks-Frankenberrry; Ryan C Burdick; DongFei Qi; Taisuke Izumi; Vinay K Pathak
Journal:  J Mol Biol       Date:  2013-11-02       Impact factor: 5.469

3.  The Evolutionary Histories of Antiretroviral Proteins SERINC3 and SERINC5 Do Not Support an Evolutionary Arms Race in Primates.

Authors:  Ben Murrell; Thomas Vollbrecht; John Guatelli; Joel O Wertheim
Journal:  J Virol       Date:  2016-08-26       Impact factor: 5.103

Review 4.  Human MX2/MxB: a Potent Interferon-Induced Postentry Inhibitor of Herpesviruses and HIV-1.

Authors:  Peter Staeheli; Otto Haller
Journal:  J Virol       Date:  2018-11-27       Impact factor: 5.103

Review 5.  Tetherin/BST-2: Restriction Factor or Immunomodulator?

Authors:  Sam X Li; Bradley S Barrett; Kejun Guo; Mario L Santiago
Journal:  Curr HIV Res       Date:  2016       Impact factor: 1.581

Review 6.  Structure-guided analysis of the human APOBEC3-HIV restrictome.

Authors:  Halil Aydin; Matthew W Taylor; Jeffrey E Lee
Journal:  Structure       Date:  2014-03-20       Impact factor: 5.006

7.  HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase.

Authors:  David C Goldstone; Valerie Ennis-Adeniran; Joseph J Hedden; Harriet C T Groom; Gillian I Rice; Evangelos Christodoulou; Philip A Walker; Geoff Kelly; Lesley F Haire; Melvyn W Yap; Luiz Pedro S de Carvalho; Jonathan P Stoye; Yanick J Crow; Ian A Taylor; Michelle Webb
Journal:  Nature       Date:  2011-11-06       Impact factor: 49.962

Review 8.  Structural Insights into APOBEC3-Mediated Lentiviral Restriction.

Authors:  Krista A Delviks-Frankenberry; Belete A Desimmie; Vinay K Pathak
Journal:  Viruses       Date:  2020-05-27       Impact factor: 5.048

9.  The GTPase Domain of MX2 Interacts with the HIV-1 Capsid, Enabling Its Short Isoform to Moderate Antiviral Restriction.

Authors:  Gilberto Betancor; Matthew D J Dicks; Jose M Jimenez-Guardeño; Nabil H Ali; Luis Apolonia; Michael H Malim
Journal:  Cell Rep       Date:  2019-11-12       Impact factor: 9.423

Review 10.  Restriction Factors: From Intrinsic Viral Restriction to Shaping Cellular Immunity Against HIV-1.

Authors:  Marta Colomer-Lluch; Alba Ruiz; Arnaud Moris; Julia G Prado
Journal:  Front Immunol       Date:  2018-12-06       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.